Dose Modification Dynamics of Ponatinib in Patients with Chronic- Phase Chronic Myeloid Leukemia (CP-CML) from the PACE and Optic Trials

被引：8

作者：

J.Jabbour, Elias ^{[1
]}

W.Deininger, Michael ^{[2
]}

bruzzese, Elisabetta A. ^{[3
]}

Apperley, jane F.

E.Cortes, Jorge ^{[4
,5
]}

Chuah, Charles ^{[6
]}

J.DeAngelo, Daniel ^{[7
]}

F.DiPersio, John ^{[8
]}

Hochhaus, Andreas ^{[9
]}

H.Lipton, Jeffrey ^{[10
]}

E.Nicolini, Franck ^{[11
]}

Ibarz, Javier Pinilla ^{[12
]}

Rea, Delphine ^{[13
]}

Rosti, Gianantonio ^{[14
]}

Rousselot, Philippe ^{[15
]}

J.Mauro, Michael ^{[16
]}

Shah, Neil P. ^{[17
]}

Talpaz, Moshe ^{[18
]}

Vorog, Alexander ^{[19
]}

Lu, Vickie ^{[19
]}

Kantarjian, Hagop ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[2] Univ Utah, Huntsman Canc Inst, Div Hematol & Hematol Malignancies, Salt Lake City, UT USA

[3] Tor Vergata Univ, S Eugenio Hosp, Hematol, Rome, Italy

[4] Imperial Coll London, Dept Med, Ctr Haematol, London, England

[5] Augusta Univ, Georgia Canc Ctr, Augusta, GA USA

[6] Singapore Gen Hosp, Duke NUS Med Sch, Singapore, Singapore

[7] Dana Farber Canc Inst, Boston, MA USA

[8] Washington Univ Sch Med, Div Oncol, St Louis, MO USA

[9] Univ Jena, Jena, Germany

[10] Hans Messner Allogene Blood & Marrow Transplant U, Princess Margaret Canc Ctr, Toronto, ON, Canada

[11] Ctr Hospitalier Lyon Sud, F-03 Lyon, France

[12] H Lee Moffitt Canc Ctr Res Inst, Tampa, FL USA

[13] Hop St Louis, Paris, France

[14] IRCCS Ist Romagnolo Studio Tumori IRST Dino Amado, Meldola, Italy

[15] Univ Versailles St Que, Ctr Hospitalier Versailles, Paris, France

[16] Mem Sloan Kettering Canc Ctr, New York, NY USA

[17] Univ Calif San Francisco, Div Hematol & Oncol, San Francisco, CA USA

[18] University of Michigan, Comprehensive Cancer Center, Ann Arbor, MI USA

[19] University of Michigan, Comprehensive Cancer Center, Ann Arbor, MI USA

来源：

BLOOD | 2021年 / 138卷

关键词：

D O I：

10.1182/blood-2021-146175

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2550

引用

页数：7

共 50 条

[1] Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials
Jabbour, Elias
Apperley, Jane
Cortes, Jorge
Rea, Delphine
Deininger, Michael
Abruzzese, Elisabetta
Chuah, Charles
Deangelo, Daniel J.
Hochhaus, Andreas
Lipton, Jeffrey H.
Mauro, Michael
Nicolini, Franck
Pinilla-Ibarz, Javier
Rosti, Gianantonio
Rousselot, Philippe
Shah, Neil P.
Talpaz, Moshe
Vorog, Alexander
Ren, Xiaowei
Kantarjian, Hagop
LEUKEMIA, 2024, 38 (03) : 475 - 481
[2] Correction: Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials
Jabbour, Elias
Apperley, Jane
Cortes, Jorge
Rea, Delphine
Deininger, Michael
Abruzzese, Elisabetta
Chuah, Charles
Deangelo, Daniel J.
Hochhaus, Andreas
Lipton, Jeffrey H.
Mauro, Michael
Nicolini, Franck
Pinilla-Ibarz, Javier
Rosti, Gianantonio
Rousselot, Philippe
Shah, Neil P.
Talpaz, Moshe
Vorog, Alexander
Ren, Xiaowei
Kantarjian, Hagop
LEUKEMIA, 2024, 38 (10) : 2291 - 2291
[3] Dose Modification Dynamics of Ponatinib in Patients With Chronic-Phase Chronic Myeloid Leukemia From the PACE and OPTIC Trials
Apperley, Jane
Kantarjian, Hagop
Deininger, Michael
Abruzzese, Elisabetta
Cortes, Jorge
Chuah, Charles
DeAngelo, Daniel J.
DiPersio, John
Hochhaus, Andreas
Lipton, Jeffrey H.
Nicolini, Frank
Pinilla-Ibarz, Javier
Rea, Delphine
Rosti, Gianantonio
Rousselot, Philippe
Mauro, Michael
Shah, Neil
Talpaz, Moshe
Vorog, Alexander
Ren, Xiaowei
Jabbour, Elias
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S284 - S285
[4] Efficacy and Safety Of Ponatinib Following Failure Of Nilotinib In Patients With Chronic Phase Chronic Myeloid Leukemia (CP-CML) In The PACE Trial
Kantarjian, Hagop M.
Cortes, Jorge E.
Kim, Dong-Wook
Pinilla-Ibarz, Javier
le Coutre, Philipp D.
Paquette, Ronald
Chuah, Charles
Nicolini, Franck E.
Apperley, Jane F.
Khoury, H. Jean
Talpaz, Moshe
DiPersio, John F.
DeAngelo, Daniel J.
Abruzzese, Elisabetta
Rea, Delphine
Baccarani, Michele
Mueller, Martin C.
Gambacorti-Passerini, Carlo
Lustgarten, Stephanie
Rivera, Victor M.
Clackson, Tim
Turner, Christopher D.
Haluska, Frank G.
Guilhot, Francois
Deininger, Michael W.
Hochhaus, Andreas
Hughes, Timothy P.
Goldman, John M.
Shah, Neil P.
BLOOD, 2013, 122 (21)
[5] Efficacy and Safety Of Ponatinib Following Failure Of Dasatinib In Patients (pts) With Chronic Phase Chronic Myeloid Leukemia (CP-CML) In The PACE Trial
Hochhaus, Andreas
Cortes, Jorge E.
Kim, Dong-Wook
Pinilla-Ibarz, Javier
le Coutre, Philipp D.
Paquette, Ronald
Chuah, Charles
Nicolini, Franck E.
Apperley, Jane F.
Khoury, H. Jean
Talpaz, Moshe
DiPersio, John F.
DeAngelo, Daniel J.
Abruzzese, Elisabetta
Rea, Delphine
Baccarani, Michele
Mueller, Martin C.
Gambacorti-Passerini, Carlo
Lustgarten, Stephanie
Rivera, Victor M.
Clackson, Tim
Turner, Christopher D.
Haluska, Frank G.
Deininger, Michael W.
Hughes, Timothy P.
Goldman, John M.
Shah, Neil P.
Kantarjian, Hagop M.
Guilhot, Francois
BLOOD, 2013, 122 (21)
[6] 4-Year Results With Ponatinib by Mutation Status in Patients With Chronic-Phase Chronic Myeloid Leukemia (CP-CML): OPTIC Study
Deininger, Michael
Apperley, Jane
Arthur, Christopher Kevin
Chuah, Charles
Hochhaus, Andreas
de Lavallade, Hugues
Lipton, Jeffrey
Lomaia, Elza
McCloskey, James
Maness, Lori
Mauro, Michael
Moiraghi, Beatriz
Pavlovsky, Carolina
Rosti, Gianantonio
Rousselot, Philippe
Sutton, Maria Undurraga
Ren, Xiaowei
Vorog, Alexander
Kantarjian, Hagop
Cortes, Jorge
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S353 - S354
[7] Ponatinib In Heavily Pretreated Patients With Chronic Phase Chronic Myeloid Leukemia (CP-CML): Management Of Adverse Events (AEs)
Le Coutre, Philipp D.
Kim, Dong-Wook
Pinilla-Ibarz, Javier
Paquette, Ronald
Chuah, Charles
Nicolini, Franck E.
Apperley, Jane F.
Khoury, H. Jean
Talpaz, Moshe
Dipersio, John F.
DeAngelo, Daniel J.
Abruzzese, Elisabetta
Rea, Delphine
Baccarani, Michele
Muller, Martin C.
Gambacorti-Passerini, Carlo
Lustgarten, Stephanie
Yanase, Kumiko
Turner, Christopher D.
Haluska, Frank G.
Guilhot, Francois
Deininger, Michael W.
Hochhaus, Andreas
Hughes, Timothy P.
Goldman, John M.
Shah, Neil P.
Kantarjian, Hagop M.
Cortes, Jorge E.
BLOOD, 2013, 122 (21)
[8] Epic: A Phase 3 Trial of Ponatinib Compared with Imatinib in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CP-CML)
Lipton, Jeffrey H.
Chuah, Charles
Guerci-Bresler, Agnes
Rosti, Gianantonio
Simpson, David
Assouline, Sarit
Etienne, Gabriel
Nicolini, Franck E.
Le Coutre, Philipp
Clark, Richard
Stenke, Leif
Andorsky, David
Oehler, Vivian
Lustgarten, Stephanie
Rivera, Victor M.
Clackson, Tim
Haluska, Frank G.
Baccarani, Michele
Cortes, Jorge E.
Guilhot, Francois
Hochhaus, Andreas
Hughes, Timothy P.
Kantarjian, Hagop M.
Shah, Neil P.
Talpaz, Moshe
Deininger, Michael W.
BLOOD, 2014, 124 (21)
[9] COST-EFFECTIVENESS ANALYSIS OF PONATINIB IN THE TREATMENT OF CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) IN SWEDEN
Iannazzo, S.
McGarry, L.
Chiroli, S.
VALUE IN HEALTH, 2015, 18 (07) : A668 - A668
[10] COMPARISON OF PACE CLINICAL TRIAL VS REAL-WORLD PONATINIB PRESCRIBING AND DURATION OF THERAPY IN CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML) PATIENTS
Mauro, M.
McGarry, L. J.
Yang, M.
Lustgarten, S.
Huang, H.
HAEMATOLOGICA, 2016, 101 : 458 - 458

← 1 2 3 4 5 →